Document Detail


Endoscopic pancreatic function test using combined secretin and cholecystokinin stimulation for the evaluation of chronic pancreatitis.
MedLine Citation:
PMID:  22281107     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Current endoscopic pancreatic function test (ePFT) methods use either secretin or cholecystokinin (CCK) to measure pancreatic function. OBJECTIVE: To evaluate a novel ePFT protocol that includes both secretin and CCK stimulation and to assess which fluid parameters best discriminate patients with chronic pancreatitis (CP). DESIGN: Prospective, cross-sectional diagnostic study. SETTING: Single, tertiary-care institution. PATIENTS: Healthy volunteers and patients evaluated for CP were included. INTERVENTIONS: All patients underwent a combined secretin-CCK ePFT. Patients evaluated for CP also underwent EUS during the same endoscopic session. MAIN OUTCOME MEASUREMENTS: Duodenal fluid bicarbonate, lipase, and amylase concentrations were measured after CCK and secretin stimulation. Results were compared based on the presence of CP detected by EUS (≥5 features). RESULTS: Twenty healthy volunteers and 69 patients evaluated for CP completed the secretin and CCK ePFT. Patients with an EUS score of 5 or higher had significantly decreased peak bicarbonate concentrations (72 mmol) compared with patients with an EUS score lower than 5 (90 mmol) and healthy subjects (108 mmol) (P < .001). Peak concentrations of amylase and lipase and total fluid volume were not significantly different between patients with CP and controls. Receiver-operating characteristic analysis revealed that peak bicarbonate concentration had superior discrimination for CP (area under the curve [AUC] 0.738) compared with peak amylase (AUC 0.677) and peak lipase (AUC 0.627). The addition of enzyme concentration measurement did not improve discrimination compared with peak bicarbonate alone. LIMITATIONS: Secretin and cholecystokinin endoscopic pancreatic function test (SC ePFT) results were not compared with those of single hormone ePFTs. CONCLUSIONS: The addition of CCK infusion and enzyme concentration measurement to a standard secretin ePFT does not enhance the diagnosis of CP.
Authors:
Ryan Law; Rocio Lopez; Adele Costanzo; Mansour A Parsi; Tyler Stevens
Related Documents :
9657577 - Deposition and clearance of inhaled 18fdg powder in patients with chronic obstructive p...
22084737 - Does radioiodine therapy in patients with differentiated thyroid cancer increase the fr...
12375707 - Assessment of diurnal variability of peak expiratory flow in stable asthmatics.
18609077 - Transient elevation of neutrophil proteinases in induced sputum during copd exacerbation.
1562407 - A prospective comparison of 99mtc-labeled polyclonal human immunoglobulin and 111in gra...
8164217 - Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-24
Journal Detail:
Title:  Gastrointestinal endoscopy     Volume:  -     ISSN:  1097-6779     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0010505     Medline TA:  Gastrointest Endosc     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.
Affiliation:
Medicine Institute, The Cleveland Clinic, Cleveland, Ohio, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of ?-sy...
Next Document:  Internal hypoechoic feature by EUS as a possible predictive marker for the enlargement potential of ...